Zevra Therapeutics
ZVRA
#6706
Rank
NZ$0.85 B
Marketcap
$15.99
Share price
2.14%
Change (1 day)
114.63%
Change (1 year)

Revenue for Zevra Therapeutics (ZVRA)

Revenue in 2024 (TTM): NZ$31.83 Million

According to Zevra Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$32.98 Million. In 2022 the company made a revenue of NZ$16.47 Million a decrease over the revenue in the year 2021 that were of NZ$41.94 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Zevra Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$31.83 M
2022 NZ$16.47 M-60.73%
2021 NZ$41.94 M127.76%
2020 NZ$18.41 M-3.4%
2019 NZ$19.06 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A